About us stage image

Medical Technology segment of ZEISS

We improve the quality of life of patients and drive the progress, efficiency and access to healthcare.

ZEISS Medical Technology

The Medical Technology segment of ZEISS offers complete solutions to diagnose and treat ophthalmic diseases. In the field of microsurgery the company provides innovative visualization solutions.

With a special focus on ophthalmology, ophthalmic surgery and visualization systems in the field of microsurgery, the company supports healthcare professionals in setting new standards of care with proven medical technology and broad application competence based on cutting-edge innovations. ZEISS also offers visualization solutions for dental treatment and gynecology. The company's medical technology portfolio is completed by future-oriented technologies such as intraoperative radiotherapy.

Company overview

The Medical Technology activities of ZEISS are today largely bundled under the umbrella of the TecDAX-listed company Carl Zeiss Meditec AG in which Carl Zeiss AG holds ca. 59 percent interest.
Besides its headquarters in Jena/Germany, the Carl Zeiss Meditec AG has subsidiaries in the USA, Japan, Germany, Spain, France, Turkey and UK. Additional ZEISS Research and Development Centers in India and China strengthen the company's presence in these rapidly developing economies. In other countries the company makes use of the vaste distribution network of ZEISS.
Management board
Dr. Markus Weber (President and CEO)

Justus Felix Wehmer (CFO)


The Carl Zeiss Meditec Group generated revenue of €2,089.3m in fiscal year 2022/23 (to 30 September).1


Carl Zeiss Meditec Group has approximately 4,823 employees worldwide.1

Social commitment at ZEISS Medical Technology

  • 15%

    of revenue invested in research and development

  • 13

    ICO and IOFF fellows have been supported by ZEISS since 2012

  • 170k

    170,000 fewer hours worked

  • 1

    Revenue and Number of employees deviate from the published figures of the Medical Technology Segment of Carl Zeiss AG as a result of different consolidation models.